PERCEPTIVE ADVISORS LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$7.7B
Holdings
148
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (148 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 3,185,898 | $514.6B | 6691.25% | |
| 2 | BBIOBRIDGEBIO PHARMA INC | 7,756,928 | $472.9B | 6148.33% | |
| 3 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,849,912 | $399.7B | 5196.80% | |
| 4 | TVTX 2.5 09/15/25RETROPHIN INC | 45,000,000 | $384.4B | 4998.40% | |
| 5 | IOVAIOVANCE BIOTHERAPEUTICS INC | 10,959,772 | $285.2B | 3707.92% | |
| 6 | AM6AMICUS THERAPEUTICS INC | 23,121,329 | $222.9B | 2898.10% | |
| 7 | —COLLEGIUM PHARMACEUTICAL INC | 17,500,000 | $189.7B | 2466.85% | |
| 8 | HZNPHORIZON THERAPEUTICS PUB L | 1,985,002 | $185.9B | 2416.82% | |
| 9 | VAC2USDVBI VACCINES INC CDA | 55,042,465 | $184.4B | 2397.53% | |
| 10 | —LANDOS BIOPHARMA INC | 14,869,915 | $171.7B | 2233.12% | |
| 11 | NVTA1EURINVITAE CORP | 4,818,801 | $162.5B | 2113.38% | |
| 12 | NVRO 2.75 04/01/25NEVRO CORP | 9,000,000 | $156.3B | 2031.96% | |
| 13 | —ZYMEWORKS INC | 4,305,600 | $149.4B | 1942.05% | |
| 14 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 4,152,689 | $145.4B | 1890.90% | |
| 15 | NVROEURNEVRO CORP | 818,760 | $135.7B | 1764.97% | |
| 16 | RCKTROCKET PHARMACEUTICALS INC | 2,751,603 | $121.9B | 1584.57% | |
| 17 | OMGBPOUTSET MED INC | 2,387,535 | $119.3B | 1551.56% | |
| 18 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 4,643,095 | $119.0B | 1546.71% | |
| 19 | ALDXALDEYRA THERAPEUTICS INC | 9,903,879 | $112.2B | 1459.01% | |
| 20 | UTHUNITED THERAPEUTICS CORP DEL | 616,802 | $110.7B | 1438.84% | |
| 21 | MGTXMEIRAGTX HLDGS PLC | 6,948,277 | $107.7B | 1400.33% | |
| 22 | NAUTNAUTILUS BIOTECHNOLOGY INC | 8,911,151 | $90.0B | 1170.24% | |
| 23 | CCCCC4 THERAPEUTICS INC | 2,258,566 | $85.5B | 1111.23% | |
| 24 | —SINGULAR GENOMICS SYSTEMS IN | 3,082,870 | $84.7B | 1101.52% | |
| 25 | BDQMALBIREO PHARMA INC | 2,360,139 | $83.0B | 1079.59% | |
| 26 | —PROMETHEUS BIOSCIENCES INC | 3,314,032 | $81.4B | 1058.30% | |
| 27 | NBIXNEUROCRINE BIOSCIENCES INC | 811,832 | $79.0B | 1027.28% | |
| 28 | RAPTEURRAPT THERAPEUTICS INC | 2,520,660 | $78.8B | 1024.38% | Put |
| 29 | CRNXCRINETICS PHARMACEUTICALS IN | 3,963,517 | $74.7B | 971.43% | |
| 30 | RLAYRELAY THERAPEUTICS INC | 2,018,097 | $73.8B | 960.12% | |
| 31 | BEAMBEAM THERAPEUTICS INC | 537,635 | $69.2B | 899.75% | |
| 32 | —ZYMERGEN INC | 1,633,332 | $65.3B | 849.69% | |
| 33 | CHRSCOHERUS BIOSCIENCES INC | 4,697,612 | $65.0B | 844.74% | |
| 34 | ATNXEURATHENEX INC | 13,532,467 | $62.5B | 812.91% | |
| 35 | ESTAESTABLISHMENT LABS HLDGS INC | 700,408 | $61.2B | 795.41% | |
| 36 | —KADMON HLDGS INC | 15,711,334 | $60.8B | 790.58% | |
| 37 | KRON1USDKRONOS BIO INC | 2,528,052 | $60.5B | 787.25% | |
| 38 | —QUOTIENT LTD | 16,200,818 | $59.0B | 766.76% | |
| 39 | MGNXMACROGENICS INC | 2,148,060 | $57.7B | 750.20% | |
| 40 | MDTMEDTRONIC PLC | 450,000 | $55.9B | 726.29% | |
| 41 | MORFMORPHIC HLDG INC | 938,140 | $53.8B | 700.05% | |
| 42 | SLDBSOLID BIOSCIENCES INC | 13,412,552 | $49.1B | 638.29% | |
| 43 | AVIRATEA PHARMACEUTICALS INC | 2,259,224 | $48.5B | 630.98% | |
| 44 | —COHERUS BIOSCIENCES INC | 4,500,000 | $46.1B | 598.80% | |
| 45 | —CAREMAX INC | 3,320,000 | $42.8B | 556.87% | |
| 46 | —DBV TECHNOLOGIES S A | 7,695,505 | $42.0B | 546.32% | |
| 47 | APLSAPELLIS PHARMACEUTICALS INC | 661,162 | $41.8B | 543.30% | |
| 48 | VRCAVERRICA PHARMACEUTICALS INC | 3,610,412 | $40.8B | 530.47% | |
| 49 | —RAIN THERAPEUTICS INC | 2,537,019 | $39.4B | 512.62% | |
| 50 | TMCITREACE MED CONCEPTS INC | 1,235,886 | $38.6B | 502.33% | |
| 51 | TARSTARSUS PHARMACEUTICALS INC | 1,296,416 | $37.6B | 488.50% | |
| 52 | AXSMAXSOME THERAPEUTICS INC | 553,908 | $37.4B | 485.86% | |
| 53 | VERUEURVERU INC | 4,451,342 | $35.9B | 467.07% | |
| 54 | —ATHIRA PHARMA INC | 3,425,916 | $35.1B | 456.14% | |
| 55 | HCATHEALTH CATALYST INC | 566,084 | $31.4B | 408.57% | |
| 56 | XENEXENON PHARMACEUTICALS INC | 1,678,973 | $31.3B | 406.48% | |
| 57 | —DICERNA PHARMACEUTICALS INC | 800,000 | $29.9B | 388.20% | |
| 58 | BCABBIOATLA INC | 685,519 | $29.1B | 377.74% | |
| 59 | EXASEXACT SCIENCES CORP | 233,523 | $29.0B | 377.45% | |
| 60 | IMTXIMMATICS N.V | 2,500,000 | $29.0B | 377.39% | |
| 61 | NARIUSDINARI MED INC | 310,437 | $29.0B | 376.52% | |
| 62 | OPHTEURIVERIC BIO INC | 4,585,512 | $28.9B | 376.22% | |
| 63 | XLRNACCELERON PHARMA INC | 226,760 | $28.5B | 370.00% | |
| 64 | NUVBNUVATION BIO INC | 3,041,004 | $28.3B | 368.12% | |
| 65 | ATECALPHATEC HLDGS INC | 1,800,180 | $27.6B | 358.59% | |
| 66 | TVTXTRAVERE THERAPEUTICS INC | 1,845,555 | $26.9B | 350.11% | |
| 67 | GRPHGRAPHITE BIO INC | 875,093 | $26.9B | 349.66% | |
| 68 | RNAAVIDITY BIOSCIENCES INC | 1,079,028 | $26.7B | 346.68% | |
| 69 | KODKODIAK SCIENCES INC | 286,041 | $26.6B | 345.89% | |
| 70 | ADMAADMA BIOLOGICS INC | 16,584,802 | $26.5B | 345.03% | |
| 71 | RGENREPLIGEN CORP | 132,500 | $26.4B | 343.91% | |
| 72 | ARWRARROWHEAD PHARMACEUTICALS IN | 315,141 | $26.1B | 339.36% | |
| 73 | LYRALYRA THERAPEUTICS INC | 3,222,560 | $25.9B | 336.46% | |
| 74 | COGTCOGENT BIOSCIENCES INC | 3,188,750 | $25.9B | 336.25% | |
| 75 | PMVPPMV PHARMACEUTICALS INC | 746,557 | $25.5B | 331.59% | |
| 76 | INBXUSDINHIBRX INC | 907,090 | $25.0B | 324.58% | |
| 77 | TCE2CELLDEX THERAPEUTICS INC NEW | 742,699 | $24.8B | 322.93% | |
| 78 | COLLCOLLEGIUM PHARMACEUTICAL INC | 978,277 | $23.1B | 300.69% | |
| 79 | TOCAEURFORTE BIOSCIENCES INC | 685,000 | $23.0B | 299.44% | |
| 80 | STOKSTOKE THERAPEUTICS INC | 671,978 | $22.6B | 294.10% | |
| 81 | —AGILE THERAPEUTICS INC | 15,919,925 | $21.2B | 275.31% | |
| 82 | MNLOUSDVYNE THERAPEUTICS INC | 5,773,954 | $20.3B | 263.52% | |
| 83 | —ONCORUS INC | 1,463,599 | $20.2B | 262.62% | |
| 84 | CLOVCLOVER HEALTH INVESTMENTS CO | 1,500,000 | $20.0B | 259.79% | |
| 85 | VRNAVERONA PHARMA PLC | 2,888,889 | $18.9B | 245.65% | |
| 86 | DAWNDAY ONE BIOPHARMACEUTICALS I | 756,047 | $17.2B | 223.84% | |
| 87 | —1LIFE HEALTHCARE INC | 516,044 | $17.1B | 221.82% | |
| 88 | —CM LIFE SCIENCES II INC | 1,250,000 | $16.8B | 218.61% | |
| 89 | TDOCTELADOC HEALTH INC | 100,000 | $16.6B | 216.22% | Call |
| 90 | —CATABASIS PHARMACEUTICALS IN | 7,687,185 | $16.2B | 210.89% | |
| 91 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 1,000,000 | $16.2B | 210.56% | |
| 92 | IMCRIMMUNOCORE HLDGS PLC | 400,000 | $15.6B | 203.10% | |
| 93 | —NEPTUNE WELLNESS SOLUTIONS I | 12,849,706 | $15.0B | 195.48% | |
| 94 | ACRSACLARIS THERAPEUTICS INC | 850,000 | $14.9B | 194.07% | |
| 95 | —HEALTHCOR CATALIO ACQU CORP | 1,500,000 | $14.8B | 192.11% | |
| 96 | NBTXNANOBIOTIX SA | 1,059,800 | $14.6B | 189.89% | |
| 97 | VRDNVIRIDIAN THERAPEUTICS INC | 794,506 | $14.5B | 188.94% | |
| 98 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 352,804 | $14.4B | 187.44% | |
| 99 | VTRSVIATRIS INC | 1,004,419 | $14.4B | 186.62% | |
| 100 | —FUSION PHARMACEUTICALS INC | 1,775,167 | $14.3B | 186.49% |
Page 1 of 2Next